GE HEALTHCARE TECHNOLOGIES ($GEHC) posted quarterly earnings results on Wednesday, July 30th. The company reported earnings of $1.06 per share, beating estimates of $0.94 by $0.12. The company also reported revenue of $5,007,000,000, missing estimates of $5,061,929,050 by $-54,929,050.
You can see Quiver Quantitative's $GEHC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GE HEALTHCARE TECHNOLOGIES Insider Trading Activity
GE HEALTHCARE TECHNOLOGIES insiders have traded $GEHC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GEHC stock by insiders over the last 6 months:
- GEORGE A. NEWCOMB (Chief Accounting Officer) sold 2,000 shares for an estimated $185,080
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GE HEALTHCARE TECHNOLOGIES Hedge Fund Activity
We have seen 585 institutional investors add shares of GE HEALTHCARE TECHNOLOGIES stock to their portfolio, and 592 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 9,636,936 shares (-15.8%) from their portfolio in Q1 2025, for an estimated $777,797,104
- CITADEL ADVISORS LLC added 6,428,164 shares (+1316.2%) to their portfolio in Q1 2025, for an estimated $518,817,116
- EGERTON CAPITAL (UK) LLP removed 4,572,382 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $369,036,951
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,198,337 shares (-51.9%) from their portfolio in Q1 2025, for an estimated $258,137,779
- SURGOCAP PARTNERS LP removed 2,241,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $180,871,110
- D1 CAPITAL PARTNERS L.P. removed 2,237,000 shares (-64.2%) from their portfolio in Q1 2025, for an estimated $180,548,270
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,844,743 shares (-61.4%) from their portfolio in Q1 2025, for an estimated $148,889,207
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GE HEALTHCARE TECHNOLOGIES Congressional Stock Trading
Members of Congress have traded $GEHC stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GEHC stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 2 purchases worth up to $30,000 on 05/15, 02/25 and 1 sale worth up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GE HEALTHCARE TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $GEHC in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 07/09/2025
- Wells Fargo issued a "Overweight" rating on 05/01/2025
- Evercore ISI Group issued a "Outperform" rating on 05/01/2025
- Goldman Sachs issued a "Buy" rating on 05/01/2025
- Piper Sandler issued a "Overweight" rating on 04/23/2025
To track analyst ratings and price targets for GE HEALTHCARE TECHNOLOGIES, check out Quiver Quantitative's $GEHC forecast page.
GE HEALTHCARE TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $GEHC recently. We have seen 7 analysts offer price targets for $GEHC in the last 6 months, with a median target of $85.0.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $89.0 on 07/09/2025
- Patrick Wood from Morgan Stanley set a target price of $78.0 on 05/06/2025
- Graham Doyle from UBS set a target price of $73.0 on 05/05/2025
- David Roman from Goldman Sachs set a target price of $82.0 on 05/01/2025
- Larry Biegelsen from Wells Fargo set a target price of $89.0 on 05/01/2025
- Vijay Kumar from Evercore ISI Group set a target price of $85.0 on 05/01/2025
- An analyst from Piper Sandler set a target price of $88.0 on 04/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
